Results 241 to 250 of about 70,435 (286)
Some of the next articles are maybe not open access.

Familial hCG Syndrome

Journal of Reproductive Immunology, 2012
An explanation is needed for why some men and women show positive in hCG screening tests when they are not pregnant, do not have cancer and are otherwise asymptomatic. In this study, a total of 10 families comprising 30 persons with a history of positive hCG tests were investigated.
Laurence A Cole
exaly   +3 more sources

Metabolism of HCG in Man

The Journal of Clinical Endocrinology & Metabolism, 1969
ABSTRACT The metabolic clearance rate (MCR) of human chorionic gonadotropin (HCG) was determined in normal male and female subjects following the intravenous and intramuscular administration of 10,000 IU of HCG. The mean MCR (I/day) in the iv experiments was 3.38 for men and 3.86 for women.
T, Rizkallah   +2 more
openaire   +2 more sources

hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation

Journal of Reproductive Immunology, 2009
The evolution of regular chorionic gonadotropin (CG) and hyperglycosylated CG are linked with the evolution of hemochorial placentation in primates. Recent research with humans shows that regular CG promotes spiral artery angiogenesis and hyperglycosylated CG controls invasion by implanting trophoblast cells.
openaire   +2 more sources

Effect of Conformation of hCG-β on Generation of hCG-Specific Antibody

Endocrine Research Communications, 1978
Most antisera generated to isolated highly purified beta subunits of human glycoprotein hormones are not sufficiently sensitive to detect physiologic blood levels of the native hormone. In the dissociated state, beta subunits assume a conformation different from that in the native hormone.
A C, Lerario   +2 more
openaire   +2 more sources

Clinical use of HCG and hCG beta determinations.

Scandinavian journal of clinical and laboratory investigation. Supplementum, 1993
Recent advances in our understanding of hCG/hCG beta synthesis by trophoblastic and nontrophoblastic tissues together with improved techniques for measuring hCG have helped to define the role of hCG as a clinical marker. HCG determination by sensitive immunometric assay enables detection of hCG immunoreactivity in normal men and women.
K, Mann, B, Saller, R, Hoermann
openaire   +1 more source

Hyperglycosylated hCG and extravillous cytotrophoblast hCG

2022
Laurence A. Cole, Stephen A. Butler
openaire   +1 more source

Clinical Applications of hCG

1984
The concept of tumor markers has widened in recent years. In the 1950s and 1960s we thought of them primarily as means of detecting and monitoring tumors. In the past decade their potential value at the immunocytochemical level has become more evident, and now the possibilities of in vivo localization with antibodies and of drug targeting have come ...
openaire   +2 more sources

HCG Support During HMG/HCG Therapy

Fertility and Sterility, 1989
Paul G. McDonough, Donald Maier
openaire   +2 more sources

HCG or β-hCG or hCG β-subunit or hCG + hCG β-subunit?

American Journal of Obstetrics and Gynecology, 1991
openaire   +1 more source

HCG clarification

The American Journal of Clinical Nutrition, 1978
openaire   +2 more sources

Home - About - Disclaimer - Privacy